Clinical Trial Update: Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating topiramate augmentation in obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Obsessive-compulsive Disorder | Phase 4 | Status: COMPLETED